Table 1.
Summary of main characteristics for all participants
| All participants (n=15 666) | ||
|---|---|---|
| Clinical setting | ||
| Outpatient | 15 541 (99·2%) | |
| Other setting* | 125 (0·8%) | |
| Age, years | 34 (28–42) | |
| Sex | ||
| Female | 10 388 (66·3%) | |
| Male | 5278 (33·7%) | |
| ART status | ||
| On ART | 4347/15 663 (27·8%) | |
| Outpatients on ART | 4328/15 538 (27·9%) | |
| Not on ART | 11 316/15 663 (72·2%) | |
| Outpatients not on ART | 11 210/15 538 (72·1%) | |
| CD4 count, cells per μL | ||
| n | 15 281 | |
| Median | 269 (142–439) | |
| History of tuberculosis | 1955/11 148 (17·5%) | |
| W4SS | 8028/15 652 (51·3%) | |
| Cough | 4629/15 623 (29·6%) | |
| Fever | 3391/15 631 (21·7%) | |
| Weight loss | 5575/15 602 (35·7%) | |
| Night sweats | 3270/15 630 (20·9%) | |
| Cough lasting ≥2 weeks | 2205/10 919 (20·2%) | |
| Lymphadenopathy | 374/2394 (15·6%) | |
| Chest x-ray | ||
| Suggestive of tuberculosis | 1296/6177 (21·0%) | |
| Any abnormality | 2158/6222 (34·7%) | |
| Xpert positive† | 616/8625 (7·1%) | |
| Body-mass index, kg/m2 | ||
| n | 12 704 | |
| Median | 22 (19–26) | |
| C-reactive protein, mg/L‡ | ||
| n | 3582 | |
| Median | 4 (2–21) | |
| ≥10 mg/L | 1259 (35·1%) | |
| Haemoglobin, g/dL | ||
| n | 5118 | |
| Median | 12 (10–13) | |
| <10 g/dL | 1093 (21·4%) | |
Data are median (IQR), n (%), or n/N (%). If data were not available for the full cohort, the revised denominator or count is provided. ART=antiretroviral therapy. W4SS=WHO four-symptom screening.
*
One study was among people living in prison.
†
Sputum or non-sputum sample Xpert result, or both.
‡
Measured with a point-of-care assay (n=2695) or laboratory assay (n=887).